科普上層樓

難易度: **介紹新一波的研究正在揭示癌症和神經元之間的關係，並尋找可以阻止他們之間交流的方法。#propranolol # calcitonin gene-related peptide, CGRP請我喝杯咖啡吧https://open.firstory.me/join/science-up小額贊助支持本節目： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1留言告訴我你對這一集的想法： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1/commentsPowered by Firstory Hosting

難易度: ****介紹:輝瑞新冠口服藥Paxlovid (nirmatrelvir/ ritonavir)鹽野義新冠特效藥 Xocova (ensitrelvir)先諾欣XIANNUOXIN (simnotrelvir/ ritonavir)#3C-like protease #3CL protease #Pfizer #Shionogi #Simcere #Molnupiravir #LagevrioPaxlovid:Owen, D. R. et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science (2021); 374: 1586–1593.N Engl J Med. (2022); 14, 386(15):1397-1408. doi: 10.1056/NEJMoa2118542. Epub 2022 Feb 16.Xocova:Tyndall, J. D. A. S-217622, a 3CL protease inhibitor and clinical candidate for SARS-CoV-2. J. Med. Chem. (2022); 65: 6496–6498.Antimicrob Agents Chemother. (2022);18, 66(10): e0069722. doi: 10.1128/aac.00697-22. Epub 2022 Sep 13.XIANNUOXIN:Jiang, X., Su, H., Shang, W. et al. Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir. Nat Commun (2023); 14: 6463. https://doi.org/10.1038/s41467-023-42102-yOral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19 N Engl J Med (2024); 390: 230-241. DOI: 10.1056/NEJMoa2301425請我喝杯咖啡吧https://open.firstory.me/join/science-up小額贊助支持本節目： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1留言告訴我你對這一集的想法： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1/commentsPowered by Firstory Hosting

難易度: **#化療 #掉髮 #TSLP #Thymic stromal lymphopoietin #CyclinD1 #Perseus Therapeutics #tezepelumab #Tezspire #AstraZeneca請我喝杯咖啡吧https://open.firstory.me/join/science-up小額贊助支持本節目： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1留言告訴我你對這一集的想法： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1/commentsPowered by Firstory Hosting

難易度:***1>Beta放射配體藥物:Zevalin: 90Y-anti-CD20 ibritumomab tiuxetanBexxar: 131I-anti-CD20 tositumomabLutathera: 177Lu-anti-somatostatin receptor dodecanetetraacetic acid tyrosine-3-octreotate (DOTATATE)Pluvicto: 177Lu-PSMA-6172>Alpha 放射配體藥物:Xofigo: RaCl2RYZ101: 225Ac-anti-somatostatin receptor 2 (SSTR2) somatostatin analogueActinium A: 225Ac-anti-CD33 LintuzumabFPI-1434: 225Ac-anti-IGF-1R mAb#放射線治療 #放射線藥物 #放射配體 ＃radioligand therapy #RLT #Zevalin #Bexxar #Lutathera #Pluvicto # Xofigo #釔90 #碘131 #鎦177 #鐳227 #錒225 #砹211 #鉛212 #釷227 #RayzeBio #POINT Biopharma請我喝杯咖啡吧https://open.firstory.me/join/science-up小額贊助支持本節目： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1留言告訴我你對這一集的想法： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1/commentsPowered by Firstory Hosting

Powered by Firstory Hosting